Man holding chest with heart condition

Thousands to benefit as NICE approves new heart condition treatment

Thousands of NHS patients are set to benefit from a new heart condition treatment as data from clinical trials indicates improved health outcomes for patients.

The treatment known as mavacamten can benefit patients on the health service after the National Institute for Health and Care Excellence (NICE) approved its use for patients with obstructive hypertrophic cardiomyopathy.

Specifically, NICE has recommended mavacamten’s roll out for adults whose usual exercise leaves them with palpitations, shortness of breath or fatigue as a result of their condition.

Research has found that the treatment, when delivered in conjunction with standard care, is more effective that just the latter alone and that it could postpone or even avoid the need for invasive surgery.

Obstructive hypertrophic cardiomyopathy is characterised by excessive heart muscle contraction, leading to thickness and stiffness which ultimately leads to the heart not being able pump enough blood around the body.

Heart failure and stroke are just some of the complications the disease can cause, with this latest recommendation expected to benefit approximately 7,000 people.

“Obstructive hypertrophic cardiomyopathy is a disease for which, until now, there has been no specific treatment that targets its underlying cause,” NICE’s director of medicines evaluation, Helen Knight, said.

“The treatments currently used to try to manage symptoms are associated with side effects and are often ineffective. We’re therefore pleased to be able to recommend a treatment that has the potential to alter the course of obstructive hypertrophic cardiomyopathy and offer greater hope to people with it.”

Website cover

NHE May/June 2024

Join the conversation shaping the future of healthcare.

Click below to read more!

More articles...

View all
Online Conference

Presenting

2024 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Listen to industry leaders on everything within healthcare

Whether it's the latest advancements in medical technology, healthcare policies, patient care innovations, or the challenges facing healthcare providers, we cover it all.

 

Join us as we engage with top healthcare professionals, industry leaders, and policy experts to bring you insightful conversations that matter.